Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | SVP, Entertainment | October 01, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 166,803 |
Last balance in matching sequence
After 2026-10-01 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-01 · Exercise / conversion · Acquired 7,667 · Balance 174,470 F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 2 · 2026-10-01 · Sale · Disposed 6,831 · Balance 167,639 F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 3 · 2026-10-01 · Sale · Disposed 836 · Balance 166,803 F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.50 · Expires 2026-12-15 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 7,667 · Balance 0 F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 6, 2026 00:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,667 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-414725 · ownership.xml · derivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,667 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| October 01, 2026 Filed Oct 6, 2026 00:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 836 | $59.33 | $49,597.79 |
DisclosureSEC source: 0001193125-26-414725 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,803 F3 · price: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 01, 2026 Filed Oct 6, 2026 00:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,831 | $58.72 | $401,091.73 |
DisclosureSEC source: 0001193125-26-414725 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,639 F2 · price: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 01, 2026 Filed Oct 6, 2026 00:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,667 | $45.50 | $348,848.50 |
DisclosureSEC source: 0001193125-26-414725 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 174,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 48,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-394493 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,803 F1 · acquired: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:33 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,667 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-382329 · ownership.xml · derivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,667 Underlying: Class A Common Stock · 7,667 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:33 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,667 | $61.05 | $468,032.02 |
DisclosureSEC source: 0001193125-26-382329 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,727 F2 · price: The shares were sold in multiple transactions at prices ranging from $60.65 to $61.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:33 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,667 | $45.50 | $348,848.50 |
DisclosureSEC source: 0001193125-26-382329 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:11 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,667 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-335473 · ownership.xml · derivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,334 Underlying: Class A Common Stock · 7,667 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:11 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,884 | $60.11 | $413,780.03 |
DisclosureSEC source: 0001193125-26-335473 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,727 F3 · price: The shares were sold in multiple transactions at prices ranging from $59.895 to $60.385, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:11 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 783 | $59.03 | $46,223.86 |
DisclosureSEC source: 0001193125-26-335473 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,611 F2 · price: The shares were sold in multiple transactions at prices ranging from $58.89 to $59.46, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:11 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,667 | $45.50 | $348,848.50 |
DisclosureSEC source: 0001193125-26-335473 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,667 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-296456 · ownership.xml · derivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,001 Underlying: Class A Common Stock · 7,667 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,667 | $53.20 | $407,894.37 |
DisclosureSEC source: 0001193125-26-296456 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,727 F2 · price: The shares were sold in multiple transactions at prices ranging from $52.96 to $53.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,667 | $45.50 | $348,848.50 |
DisclosureSEC source: 0001193125-26-296456 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,666 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-255624 · ownership.xml · derivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,668 Underlying: Class A Common Stock · 7,666 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 508 | $56.16 | $28,529.28 |
DisclosureSEC source: 0001193125-26-255624 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,727 F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,158 | $55.59 | $397,890.31 |
DisclosureSEC source: 0001193125-26-255624 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,235 F3 · price: The shares were sold in multiple transactions at prices ranging from $55.15 to $56.105 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,666 | $45.50 | $348,803.00 |
DisclosureSEC source: 0001193125-26-255624 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 374 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| May 05, 2026 Filed May 6, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,666 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-209338 · ownership.xml · derivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,334 Underlying: Class A Common Stock · 7,666 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| May 05, 2026 Filed May 6, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 738 | $58.34 | $43,051.53 |
DisclosureSEC source: 0001193125-26-209338 · ownership.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,353 F3 · price: The shares were sold in multiple transactions at prices ranging from $58.195 to $58.36, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 05, 2026 Filed May 6, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,928 | $57.47 | $398,157.70 |
DisclosureSEC source: 0001193125-26-209338 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,091 F2 · price: The shares were sold in multiple transactions at prices ranging from $57.16 to $58.05 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 05, 2026 Filed May 6, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,666 | $45.50 | $348,803.00 |
DisclosureSEC source: 0001193125-26-209338 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 04, 2026 Filed May 6, 2026 21:05 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,688 | $58.47 | $274,083.92 |
DisclosureSEC source: 0001193125-26-209338 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,353 F1 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,667 | $64.89 | $432,588.30 |
DisclosureSEC source: 0001193125-26-037578 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,041 F1 · balance_after: Shares held following the reported transaction includes 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,612 | $66.62 | $174,011.44 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,708 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 6,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F9 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 10,557 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 6,825 PSUs. The remaining 3,732 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F9 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 10,557 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 6,825 PSUs. The remaining 3,732 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,440 | $0.00 Strike: $66.62 | $0.00 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,440 Underlying: Class A Common Stock · 56,440 shares Expires 2035-12-15 F8 · derivative.exercise_date: This option was granted for a total of 56,440 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 12,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · derivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,816 Underlying: Class A Common Stock · 12,816 shares Expires not disclosed F7 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F7 · derivative.exercise_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F7 · derivative.expiration_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 8,203 | $67.54 | $554,030.62 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,320 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 60,297 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 74,159 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 25,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323446 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,698 F1 · acquired: Award represents a total of 25,633 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 74,159 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 22:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,273 | $68.75 | $500,018.75 |
DisclosureSEC source: 0001193125-25-319384 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,065 F1 · balance_after: Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,164 | $66.12 | $407,563.68 |
DisclosureSEC source: 0001193125-25-293772 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,338 F1 · balance_after: Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 675 | $75.04 | $50,652.00 |
DisclosureSEC source: 0000950170-25-065824 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,151 F1 · balance_after: Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F8 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,513 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,990 PSUs. The remaining 2,523 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F8 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,513 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,990 PSUs. The remaining 2,523 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 36,446 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · derivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,446 Underlying: Class A Common Stock · 36,446 shares Expires 2034-12-16 F7 · derivative.exercise_date: This option was granted for a total of 36,446 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 10,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · derivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,366 Underlying: Class A Common Stock · 10,366 shares Expires not disclosed F6 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 11,703 | $79.18 | $926,643.54 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,826 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 65,762 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 20,733 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138170 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,539 F1 · acquired: Award represents a total of 20,733 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 65,762 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · derivative · entry 9 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,000 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,000 | $80.50 | $563,500.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,806 F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,000 | $64.60 | $452,200.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,000 Underlying: Class A Common Stock · 8,000 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 40,000 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 40,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 48,000 | $80.00 | $3,840,000.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,806 F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 8,000 | $64.60 | $516,800.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 40,000 | $33.15 | $1,326,000.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 23:42 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,000 | $81.00 | $162,000.00 |
DisclosureSEC source: 0000950170-24-131191 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,806 F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 239 shares and 48 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024 and November 15, 2024, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.